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These studies grew out of an investigation in which chemotherapeutic agents 
for the treatment of torulosis were being tested. Early in the investigation, 
it became clear that many of the substances had notable fungistatic action and 
appeared to be superior to the aliphatic saturated fatty acids, notably propion-
ates and undecylenates, which are at present the drugs of choice for the treatment 
of the superficial mycoses (1-2). Keeney and his coworkers, who have con-
tributed extensively to the fundamental studies on the fatty acids, found that 
the fungistatic effect of these latter compounds did not in general extend beyond 
a dilution of 1 : 1000 (3). 
EVALUTION OF FUNGISTATIC AGENTS IN VITRO 
The method is essentially a modification of the paper-disk technique used for 
the testing of antibiotics (4), and has been described elsewhere (5). It consists 
of suspending spores or other cells in an agar medium and of measuring the zone 
of inhibition obtained after placing impregnated paper disks on the surface of 
the medium. It is suitable for those fungi which form spores, or cells which can 
be suspended readily in water. Trichophyton mentagrophytes and Micro-
sporum lanosum were the test objects. The advantages of a filter paper disk 
method are that it facilitates the handling of insoluble materiTls and permits an 
estimation of the fungistatic effect of various concentrations within the fungi-
static range. For the other dermatophytes reported below, it was necessary to 
employ the conventional dilution technique, namely to dissolve or suspend the 
compound in 25% propylene glycol and to add appropriate quantities to Penn-
sylvania medium (6) at pH 6 to give the desired concentration. The final con-
centration of propylene glycol in the medium must not exceed 2.5% since it has 
some intrinsic fungistatic effect. Mter inoculation and incubation for thirty 
days, the minimal concentration producing complete fungistasis was recorded. 
For reasons given elsewhere ( 5), we consider this method less satisfactory than 
t.he paper disk technique. 
Naphthoquinones and Related Compounds. TerHorst (7) has reported the 
marked antifungal properties of 2 ,3-dichloro-1 ,4-naphthoquinone against a 
group of saprophytic fungi. Incidentally, the antimicrobial action of this com-
pound can be reversed by vitamin K (8). A related compound, tetrachloro-
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TABLE I 
Fungistatic activity of some naphthoquinones and related compounds 
PAPER DISK METHOD 
MILLIMETERS OF INHIBITION 
DILUTION METHOD 
MINIMAL Jo'UNGISTATIC CONCEN-
TR.4. TlON IN PER CENT 
COMPOUND 
5- hydroxy - 1,4- naphtha-
Trichophyton 
mentagrophytes 
Microsporum 
lanosum 
Micro-
\ 
X X o 2 sporum § ~ ~ ~- § ~ ~- ~- audouini 
- --=-1-=- - - 1- - - -
quinone ................. 51 35 28 17 22 18 14 0 0.01 
2 - chloro - 1, 4 - naphtho-
Epider-
Tr. pur- mophyton 
pureum j!occosum 
0.01 0.01 
quinone. .. 28 22 17 13 21 17 15 0 0.002 0 .01 0 .01 
2 ,3 - dichloro- 1,4- naph-
thoquinone ........ .. 32 30 22 15 27 19 0 0 0.01 0.01 
2, 3 - dichloro - 5 - hydroxy -
1,4-naphthoquinone.. . . . 30 24 1 22 17 23 19 0 0 0.01 0 .01 
2 - chloro - 3 - dimethyl-
amino- 1,4- naphthoqui-
none ...................... 55 41 22 0 
2 - chloro - 3 - (p- tolylthi-
oxy) -1,4-naphthoquinone 16 14 0 0 
2 - thiocyano - 3 - chloro -
1,4-naphthoquinone .. ..... 30 25 23 17 
2 - methyl - 1, 4 - naphtho-
quinone (1). . . . . . . . . 52 41 28 24 
2- methyl -1,4- naphthoqui-
none- 3- sodium sulfonate 
(2)...... . . . . . . 0 0 0 0 
etrasodi um diphosophoric 
ester of 2 methyl-1,4-naph-
thoquinone (3). . . . . . . . . . . 0 
2 - methoxy - 3 - chloro - 1, 4-
naphthoquinone. 21 
2-o-chloromercuriphenoxy-
3 - chloro - 1, 4 - naphtha-
0 0 0 
17 0 0 
38 26 15 0 0.002 
17 0 0 0 0.1 
26 21 16 0 0.01 
35 14 0 0 0.002 
0 0 0 0 
0 0 0 0 
I 
22 0 0 0 0.1 
quinone ................ 34. 28 17 0 30 24 17 0 0 .1 
2 - p - chlorophenoxy - 3 -
chloro- 1,4 - naphthoqui-
none. 
etraehloro 
................ 27 
- parabenzo-
quinone .... . . . . 13 
t etrachloro-hydroquinone.. . . 20 
2,2,3,4,4- pentachloro -1-
keto - tetrahydro naphtha-
lene .... . . 28 
phenanthraquinone, 9-10.. .. 40 
24 
0 
0 
20 
35 
16 
0 
0 
16 
18 
0 
0 
0 
0 
0 
31 
19 
31 
22 
26 
27 
0 
17 
17 
22 
14 
0 
0 
0 
17 
I 
0 
0 
0 
0 
0 
0.01 
0.1 
0 .01 
0.01 
0.01 
0.1 
0.002 
0 .002 
0.1 
0.002 
0 .1 
0.1 
0 .01 
0.01 
0.002 
0.01 
0.002 
0.1 
0.01 
0 .002 
0 . 1 
0.002 
0.01 
0.1 
0.002 
0.1 
(1) Vitamin K (Squibb); (2) Vitamin K (Abbott Laboratories); (3) Vitamin K (Roffman-
La Roche). 
The quinones were kindly supplied by Dr . G. L. McNew of the U.S. Rubber Company, 
Kaugatuck, Connecticut. 
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parabenzoquinone (Spergon) has been recommended (9) for the treatment of 
tinea capitis and accordingly it was included in this study for comparison. The 
results are shown in Table I-II, from which the following conclusions seem to be 
warranted: 
(1) The presence of whole blood seriously antagonizes the fungistatic activity 
of these compounds. Indeed, with tetrachloropara-benzoquinone (which is only 
TABLE II 
Effect of whole blood on the fungistatic activity of naphthoquinones and related compounds. 
(paper disk method) 
ORGANISM: TORULA HISTOLYTICA 
INHIBITION IN MILLIMETERS 
Pennsylvania medium 20 per cent blood medium 
COMPOUND 
-------------------- -- -- -- -- -- -- -- --
5-hydroxy-1,4-naphthoquinone ....... . . . ........... 22 18 16 
2-chloro-1,4-naphthoquinone ....................... 33 23 20 
2,3-dichloro-1,4-naphthoquinone ................... 27 25 23 
2, 3-dichloro-5-hydroxy-1, 4-naphthoquinone. . . . . . . . 24 18 16 
2-chloro-3-dimethylamino-1, 4-naphthoquinone. . . . . . 33 20 18 
2-chloro-3-(p-tolylthioxy)-1 ,4-naphthoquinone.. . . . . 21 18 12 
2-thiocyano-3-chloro-1 ,4-naphthoquinone... . . . . . . . . 23 20 18 
2-methyl-1,4-naphthoquinone (1) ................... 40 38 20 
2 - methyl - 1, 4 - naphthoquinone - 3 - sodium sul-
fonate (2) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 0 
tetrasodium diphosphoric ester of 2-methyl-1, 4-
naphthoquinone (3)... . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 0 
2-methoxy-3-chloro-1, 4-naphthoquinone. . . . . . . . . . . . 25 18 17 
2- o- chloromercuriphenoxy- 3- chloro -1,4- naph-
thoquinone. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 34 27 18 
2-p-chlorophenoxy-3-chloro-1, 4-naphthoquinonc. . . . 28 22 17 
etrachloro-parabenzoquinone...................... 18 17 15 
tetrachloro-hydroquinone. . . . . . . . . . . . . . . . . . . . . . . . . 25 20 0 
2, 2, 3, 4, 4-pentachloro-1-kcto-tetrahydro naphtha-
lene. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 30 25 18 
phenanthraquinone-9, 10. . . . . . . . . . . . . . . . . . . . . . . . . . . 45 43 25 
15 20 
18 18 
19 17 
15 24 
15 26 
0 0 
17 19 
11 35 
0 0 
0 0 
0 18 
16 17 
0 21 
13 0 
0 0 
1.5 0 
17 19 
16 14 
17 0 
14 0 
20 15 
14 0 
0 0 
17 14 
26 0 
0 0 
0 0 
0 0 
1~ I ~ 
0 0 
0 0 
0 0 
15 0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
(1) Vitamin K (Squibb); (2) Vitamin K (Abbott Laboratoreis); (3) Vitamin K (Roffman-
LaRoche). 
weakly active) the fungistatic effect is completely destroyed. This is a serious 
disadvantage and indicative of a tendency of this type of compound to be ren-
dered ineffective in the presence of organic material. 
(2) The chemical structure common to most of the above compounds is 
1 ,4-naphthoquinone. Simple substitutions into the ring markedly alter or 
destroy the fungistatic aetivity in a manner which cannot be predicted. 
(3) Synthetic vitamin K, 2-methyl-1 ,4-naphthoquinone, is strongly fungi-
static, but simple derivatives of it are inactive. 
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( 4) A compound which is strongly fungistatic against one of the test organisms 
generally exerts a similar effect on other fungi, implying that a common mechan-
ism underlies the phenomenon of fungistasis. 
TABLE III 
Fungistatic activity of some dithiocarbamate derivatives 
-------------------
I 
PAPER DISK METHOD 
lULLIMETERS OF INHIBITION 
- -----;------
COilPOUND 
Sodium dimethyldithiocarba-
Trichophyton 
mentagrophytes 
mate.................... 30 24 
Calcium dimethyldithiocarba-
mate .............. . 45 
Ferric dimethyldithiocarba-
mate....... . . . . . . . . 35 
2S 
25 
24 Zinc dimethyldithiocarbamate 31 
Disodium ethylene bisdithio-
68 I 55 
0 0 
carbamate ........ . 
Ethyl carbamate (1) . . ..... . 
(1) Urethane. 
TABLE IV 
Microsporum 
lanosum 
DILUTION METHOD 
ld:INIM.AL FUNGISTATIC 
CONCENTRATION (%) 
Micro- TrichoPh- Epider-
sporum mophy-
au-
yton pur- ton floc-
douini pureum co sum 
- --
--- ---
0.02 0.01 0.1 
0.02 0.002 0.01 
0.01 0.01 0.01 
0.02 0.01 0.01 
0.02 0.01 0.01 
- - -
Effect of whole blood on the fungistatic activity of dithiocarbamates (paper disk 
method: inhibition in millimeters) 
Organism: Ton<la histolytica 
PENNSYLVANIA MEDIUM 20% BLOOD MEDIUM 
COMPOUND ~_lg ~- !· ~ ~ ~ ~ !· 
-------------------------- - _:_ ,-=-1-=-
Sodium dimethyldithiocarbamate (1). . . . . . . . . . . . . . 30 19 18 14 25 13 13 0 
Calcium dimethyldithiocarbamate (2). . . . . . . . . . . . . . 51 38 35 22 30 28 22 18 
Iron dimethyldithiocarbamate (3)..... . . . . . . . . . . . . . 42 28 24 18 40 17 15 13 
Zinc dimethyldithiocarbamate (4)................. 38 33 20 18 28 18 15 13 
Disodium ethylene bisdithiocarbamate (5).... . . . . . . 55 46 38 34 51 35 27 23 
(1)-(4) Obtainable from E. I. DuPont de Nemours, Wilmington, Delaware; (5) Obtain-
able from Rohm and Haas Company, Philadelphia, Pennsylvania. 
Dithiocarbamate Derivatives. Among the many compounds which we investi-
gated, urethane (ethyl carbamate) was included. This is a drug which has 
shown promise in the treatment of leukemia. Related compounds, the dithio-
carbamates, appear to be of considerable importance as fungicides for the control 
of plant diseases (10-12). Our results with these compounds are shown in 
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Tables III and IV. It is at once evident that as a group, these substances are 
highly fungistatic for human pathogens as well. An encouraging characteristic 
is the maintenance of strong fungistatic activity in the presence of whole blood; 
it will be recalled that the naphthoquinones had a weakness in this respect. The 
sodium salt showed evidence of instability since the zone of inhibition tended to 
grow smaller a few days after the primary reading of the plate, a phenomenon 
which probably indicates the disappearance of the active agent. 
TOXICITY STUDIES 
Intraperitoneal. Suspensions of the various compounds were made in 10% 
gum acacia and injected intraperitoneally into twenty-gram white mice. Fol-
lowing the method of Reed and Muench (13) a group of five mice was used for 
TABLE V 
Median lethal doses for some quinone derivatives (20 gram mice: intraperitoneal injections) 
RATIO OF DEATHS TO NUY:BER OF 
KICE INJECTED Wim 
COJIPOUND (mg./kg.) LDiiO 
10 25 50 100 200 300 
--
-- --
--
-- -- --
mg./ 
kg. 
5-hydroxy-1, 4-naphthoquinone ........ ......... . . 3/5 5/5 - - - - <10 
2-chloro-1, 4-naphthoquinone ...... . . . . . . . . . . . . ... 5/5 5/5 - - - - <10 
2, 3-dichloro-1, 4-naphthoquinone ..... .. . - . . . . . . 1/5 2/5 5/5 - - - 25 
2, 3-dichloro-5-hydroxy-1, 4-naphthoquinone .. ... 1/5 3/5 5/5 - - - 20 
2-chloro-3-dimethylamino-1, 4-naphthoquinone. .. 0/5 0/5 1/5 5/5 - - 70 
2-thiocyano-3-chloro-1 ,4-naphthoquinone .. ..... 0/5 0/5 0/5 5/5 - - 75 
2-methyl-1,4-naphthoquinone (1) ... . . . . . . . . ..... 0/5 0/5 4/5 5/5 - - 41 
tetrachloro-parabenzoquinone (2) ........... ..... 0/5 0/5 0/5 1/5 5/5 - 170 
2, 2, 3, 4, 4 - pentachloro - 1 - keto - tetrahydro -
naphthalene .......................... . . . . . . . 0/5 0/5 1/5 4/5 5/51 
5/51 
75 
phenanthraquinone-9, 10 .............. ..... 0/5 0/5 0/5 0/5 4/5 165 
(1) Synthetic Vitamin K (Thyloquinone-Squibb); (2) Spergon. U.S. Rubber Company. 
each dosage and the dosages were increased until a concentration was found 
which killed all of them. The median lethal dose (LDso) was calculated from 
this data. The results are shown in Tables V and VI. We arbitrarily con-
sidered compounds which had a LDso that was less than 70 to be comparatively 
toxic. It is clear that the dithiocarbamates are much less toxic than the naph-
thoquinone derivatives and in fact are tolerated remarkably well in mice. Of 
course, systemic toxicity does not preclude use superficially on the skin; but 
where choices are possible, the non-toxic compounds are preferable. 
Conjunctival Tests. Five per cent concentrations of the various drugs were 
suspended in 10% gum acacia and three drops instilled into the conjunctival sac 
of the rabbit eye. The opposite eye was used for a control instillation of gum 
acacia. Observations for the development of conjunctivitis were made at 24and 
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again at 48 hours. The results are shown in Table VII. (For the sake of com-
parison, the LDoo values for mice are given for the same compound.) 
Examination of the tables shows a remarkable correlation between toxicity as 
evaluated by conjunctivitis in the rabbit eye and the LDoo values in mice. 
With but one exception (2 ,3-dichlor-1 ,4-naphthoquinone), compounds with low 
LD00 values regularly caused conjunctivitis, the degree of reaction being most 
severe with LD50 values of the order of 10 mg./kg. Conversely, compounds 
with high LDoo values are not irritant to the rabbit conjunctivae. This result 
suggests that systemic toxicity can be predicted on the basis of the reaction in 
the rabbit eye. The rabbit eye test therefore may serve as a useful preliminary 
procedure for screening out toxic drugs, since it is simple and inexpensive. In 
our opinion, this test has a particular use in investigating drugs to be used on 
TABLE VI 
Median lethal doses for some thiocarbamate derivatives (20 gram mice: 
intraperitoneal injections) 
RATIO OF DEATHS TO NUMBER OF MICE INJECTED WITH: 
COMPOUND milligrams per kilogram 
10 25 I so 100 200 300 400 500 600 700 
--
-- --
--
-- --1- -- -- --
Sodium dimethyldi-
thiocarbamate. 0/5 0/5 0/5 0/5 0/5 0/5 1;5 2/5 2/5 4/5 
Calcium dimethyl-
dithiocarbamate .. 0/5 0/5 0/5 0/5 0/5 0/5 0/5 1/5 2/5 3/5 
Ferric dimethyldi-
ihiocarbamate. 0/5 0/5 0/5 0/5 0/5 2/5 5/5 - - -
Zinc dimethyldithio-
carbamate ...... 1/5 3/5 5/5 - - - - - - -
Disodium ethylene 
0/5 I 0/5 I 0/5 bisdithiocarbamate o;5 1 o;5 0/5 0/5 3/5 2/5 4/5 
' 
LD60 
900 
-- ~-
mg./ 
kg. 
5/5 560 
5/5 630 
- 315 
- 17 
5/5 580 
the human skin. The rabbit eye reaction may eventuate as a more dependable 
and critical indicator of primary irritancy than ordinary patch testing and may 
serve as a reliable presumptive test of toxicity. 
"Excision" tests on rabbit skin. As a means of testing the reaction of the sub-
epidermal tissues to the drugs, the method of Dodd (14) was employed. Our 
simple modification of this method consisted in punching out (ordinary biopsy 
punch) a disk of rabbit skin 8 mm. in diameter as far down as the subcutis. The 
animals were anaesthetized with nembutal and the hair closely removed with 
scissors. The fungistatic agents were made up at varying concentrations in 
10% gum acacia. These were then applied to the wound with the aid of a glass 
rod in such a manner that a considerable excess of material covered all portions 
of the wound. No coverings were applied. The application of the drug was 
made daily for five consecutive days; subsequently the time required for com-
plete epithelialization of the wound was recorded. 
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The cutis failed to react to any of the compounds tested, and healing occurred 
uniformly within twelve to fourteen days with concentrations ranging from one 
to five per cent. This was true even with agents shown to be markedly toxic in 
the conjunctival tests and by parenteral injection. There was no question about 
the excess of material in the wound. Perhaps the fact that we were using sus-
TABLE VII 
Conjunctival reactions of some quinone and thiocarbamate derivatives 
(5% concentrations in gum acacia) 
Comparison with median lethal doses 
COMPOUND 
5-hydroxy-1, 4-naphthoquinone 
2-chloro-1 ,4-naphthoquinone* .. 
2, 3 - dichloro - 1, 4 - naphtho-
quinone .................... . 
2,3- dichloro -5- hydroxy -1,4-
naphthoquinone ............ . 
2 - chloro - 3 - dimethyl amino -
1, 4-naphthoquinone. . . . . . .. 
2 - thiocyano - 3 - chloro - 1, 4 -
naphthoquinone ........... . 
2- methyl - 1,4- naphthoqui-
none .................. . 
tetrachloro- para benzoquinone 
2,2,3,4,4 - pentachloro - 1 -
keto - tetrahydro - naphtha-
lene ........................ . 
phenanthraquinone-9, 10 ..... . 
sodium dimethyldithiocarba-
mate ....................... . 
calcium dimethyldithiocarba-
mate ...................... . 
ferric dimethyldithiocarbam-
atc ......................... . 
zinc dimethyldithiocarbamate. 
disodium ethylene bisdithio-
carbamate ................. . 
DEGREE OF CONJUNCTIVAL REACTION 
Rabbit I Rabbit II Rabbit Ill 
--~~-4_8_hr_. ___ z4_hr_. ___ 4_8_hr_. ___ 24_h_r. ___ 48_h_r. __ _ 
mg./kg. 
+++ . +++ +++ +++ +++ +++ <10 
+:+ +:+ +:+ +:+1+:+ +:+ <: 
+++ 
+++ 
0 
+++ 
0 
± 
0 
0 
0 
0 
++ 
0 
+++ 
+++ 
0 
+++ 
0 
0 
0 
0 
0 
0 
++ 
0 
+++ 
+++ 
+ 
+++ 
0 
± 
+ 
0 
0 
0 
++ 
0 
+++ 
+++ 
0 
+++ 
0 
0 
+ 
0 
0 
0 
+ 
0 
+++ 
+++ 
+ 
+++ 
0 
0 
0 
0 
0 
0 
+ 
0 
+++ 
+++ 
0 
+++ 
0 
0 
0 
0 
0 
0 
+ 
0 
20 
70 
75 
41 
170 
75 
165 
560 
630 
315 
17 
580 
*Two rabbits developed a keratitis as well as a severe conjunctivitis. 
pensions rather than solutions accounted for the unexpected results. Again, the 
normal exudation following trauma of this sort may have erected a barrier which 
prevented adequate contact with the drug. In any event, the method proved 
valueless for our purposes; moreover, it is time-consuming and awkward. 
Patch Tests. Twenty-five individuals were patch-tested to the various drugs, 
made up in 5% concentration in a base consisting of 45% propylene glycol and 
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55% Carbowax 4000. This is twice the concentration that we are recommend-
ing for clinical use. Since all of these drugs are strongly fungistatic at 1: 1000 
and are inhibitory in concentrations considerably less than this, it1 appears that a 
2.5% concentration provides at least a (25 fold) safety factor. This concentra-
tion presumptively insures that effective fungistatic strengths· can be safely 
applied to the skin. The following drugs which had survived the afore-described 
"screening procedures" were used: 
Calcium dimethyldithiocarbamate 
Ferric dimethyldithiocarbamate 
Disodium ethylene bisdithiocarbamate 
2-thiocyano-3-chloro-1, 4-naphthoquinone 
Phenanthraquinone-9, 10 
2,2 ,3 ,4,4-pentachloro-1-keto-tetrahydro naphthalene 
Zinc dimethyldithiocarbamate and 5-hydroxy-1 ,4-naphthoquinone were de-
liberately included in this group as "actively toxic" controls, since both of them 
TABLE VIII 
Stability of 5% ointments containing dithiocarbamates and quinone 
deri'Vatives (paper disk method: inhibition in millimeters) 
TRICHOPHYTON llENTAGRQ- lliC:ROSPO:RUU: LANOSUK PHYTES 
CO>LPOUND 
4 wks. 6 wks. 8 wks. 4~ks. 6wks. 8 wks. 
-- ------ -- --
Phenanthraquinone-9, 10 ........................ 58 53 59 66 72 65 
2-thiocyano-3-chloro-1, 4-naphthoquinone ........ 26 24 29 33 29 31 
Calcium dimethyl dithiocarbamate .............. >90 >90 >90 >90 >90 >90 
Ferric dimethyl dithiocarbamate ................ 78 83 81 87 81 85 
Disodium ethylene bisdithiocarbamate .......... >90 >90 >90 >90 >90 >90 
caused conjunctivitis in the rabbit eye and had low LD6o values; very severe skin 
reactions developed in response to patch-testing with the latter compound. 
There were no reactions on human skin to zinc dimethyldithiocarbamate, a 
result which we do not consider contradictory since the skin is a more resistant 
tissue than the conjunctiva. The toxicity of this compound is clearly due to 
the zinc ion and for this reason its superficial use is not automatically precluded. 
There were two weakly positive reactions to 2, 2, 3, 4, 4-pentachloro-1-keto-
tetrahydro naphthalene; this had caused only a slight conjunctivitis in the rabbit 
eye. Exclusive of this, there were no skin reactions to the drugs which had not 
caused conjunctivitis. 
STABILITY OF FUNGISTATIC AGENTS IN OINTMENT BASES 
It is of primary importance that drugs for clinical use should not deteriorate 
with age. Consequently, we tested the stability of these compounds in 5% 
concentration, made up in a propylene glycol and Carbowax 4000 base. The 
results are shown in Table VIII, from which it can be seen that little or no de~ 
terioration occurred within the eight-week experimental period. All of these 
agents will withstand heating to 120°C. for 30 minutes. 
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DISCUSSION 
On the basis of the data reported above, we have selected the following drugs 
as most promising for clinical trial in the treatment of the superficial mycoses 
(all to be used in 2.5% concentration, possibly less): 
1. Disodium ethylene bisdithiocarbamate1• This material is sold as a water-
soluble, yellow liquid in a concentration of 33%. It has a slightly objectionable 
sulphide odor which undoubtedly can be masked. A pure white crystalline 
material will probably be available for medical use. A yellow color is formed 
when this is dissolved in water, and the odor is still present. In view of its low 
toxicity, water-solubility and marked fungistatic action in the presence of whole 
blood, we believe it to be the most promising of all the drugs we have tested. 
Using Emmons' fungicidal test (14) with T. mentagrophytes '# 640, this ma-
terial is fungicidal at 1: 1000 for five minutes. It is also bacteriostatic, espe-
cially against gram positive organisms. It inhibits the growth of Escherichia 
coli at 1: 10,000; Eberthella typhosa at 1:5000, and Staphylococcus aureus at 
1:100,000. 
2. Calcium dimethyldithiocarbamate2 • This material is a white crystalline 
substance, odorless and only slightly soluble in water. It is not inactivated by 
blood. Its bacteriostatic effect is somewhat less than that of the above com-
pound, but is nonetheless appreciable. 
3. Ferric dimethyldithiocarbamate3• This is a black crystalline substance 
quite insoluble in water. It has no odor and is completely stable. The zinc salt 
may be more preferable since it is pure white and is otherwise similar. Both of 
these derivatives maintain their fungistatic activity in the presence of whole 
blood. 
4. Phenanthraquinone-9, 104 • This is a, yellow, crystalline odorless material 
completely insoluble in water. This is the compound we selected from the 
''naphthoquinone" group as being the most promising. Its fungistatic effect is 
notably reduced in the presence of whole blood and it is moderately non-toxic. 
We have not investigated its bacteriostatic properties. 
The physical properties of all four compounds are such that they can be made 
up in ointment or powder bases. 
SUMMARY 
Twenty-three quinone and dithiocarbamate derivatives have been investigated 
in vitro for their fungistatic activity. Data as to toxicity are given in terms of 
LD50's, conjunctival reactions and patch tests. The dithiocarbamates are su-
perior in respect to toxicity and fungistatic activity; they are not inactivated in 
the presence of blood as are the naphthoquinones. The dithiocarbamates have 
been shown to be bacteriostatic also, especially against gram positive organisms. 
'Rohm and Haas Company, Philadelphia, Pennsylvania. 
2 E. I. Du Pont de Nemours, Wilmington, Delaware. 
a E. I. DuPont de Nemours, Wilmington, Delaware. 
4 U.S. Rubber Company, Naugatuck, Connecticut. 
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